I can certainly understand why you feel gyped - I would too. Fortunately, it seems to be turning out OK, but I think you have every reason to feel frustrated and annoyed by your downgraded scores.
I agree with TurpT1a that it's probably a misread. It's not easy to determine a Gleason score, and takes a lot of training and expertise. Most pathologists are hired to read all kinds of cell types, and are not specialists at Gleason grading. The lack of concordance between pathologists at community centers and the experts like Epstein, Bostwick or Oppenheimer is troubling. Often it's not enough to make a difference in the treatment plan, but sometimes it is.
Grading accuracy is not so much an issue in post-RP pathology because of the greater amount of tissue sampled. PDA has explained that the way they slice it can make a difference, but generally the post-RP path is definitive.
Most of the time, the two match. about
1 of 4 times, there is an upgrade, and about
1 in 10 times, a downgrade. There was a change in the Gleason grading system in 2005. Some pathologists never got on board with the new standards.
Here's a European study of pathologists showing how varied they are in their grading.
In another European study among 337 pathologists only 71% agreed with the expert consensus on Gleason 6, and only 56% agreed on Gleason 7s.
Even the experts can disagree, but perhaps not so much that it would make a difference. I've known a couple of guys who had both Bostwick and Epstein read their slides. The only disagreements were in the relative percents, but not in the scores.
- Allen